The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.

People who get their news from an ideologically diverse array of sources are more likely to get vaccinated, regardless of their political affiliation, new University of Colorado Boulder research shows ...

Rising diagnoses of certain cancers in people under 50 predate the rollout of COVID-19 vaccines by decades, undermining ...

Jan. 20, 2025, marks five years since the CDC reported the first laboratory-confirmed case of COVID-19 on American soil.

As of Jan. 20, the CDC reports that RSV activity has peaked in most of the U.S., particularly among young children—a group ...

The mRNA-1273.815 vaccine provided significant protection against COVID-19-related hospitalizations and medically attended COVID-19 among US adults.

RNA vaccines have been a long time coming, but were only approved after covid-19 emerged, marking the beginning of a new way of preventing – and treating – various conditions ...

A recent study by Emory University researchers provides new insights into why the mRNA vaccines developed to fight COVID-19 ...

Patients who received the original 2-dose monovalent mRNA COVID-19 vaccine series were less likely than unvaccinated individuals to be hospitalized for COVID-19-associated venous thromboembolism.

Three main themes may largely explain COVID-19 vaccine hesitancy among Black women in the United States: mistrust in health ...

Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022, according to the first research study to look ...